An Analysis of Anonymization Practices in Initial Data Releases Pursuant to EMA Policy 0070
Mock-ups and specimens review
WHO urges countries to keep using AstraZeneca vaccine as 'benefits outweigh risks' - MarketWatch
European Medicines Agency green lights Pfizer COVID-19 pill
Expanded access and commercial packaging for niche-market drugs
Information on medicinal products - EUPATI Toolbox
EFPIA EPI report_Full_rev8.indd
Mock-ups and specimens review
Developing OTC syrup packaging for the highly regulated EU market - European Pharmaceutical Review
201310108_Prizzi_M_EMA review process of medicines labelling and packaging_rev 08.10.13
EFPIA EPI report_Full_rev8.indd
IRIS Quick Guide to Registration
Pre-authorisation guidance | European Medicines Agency
.jpg?$responsive$&cropPathE=mobile&fit=stretch,1&fmt=pjpeg&wid=640 "Interview: The Blue Box inventor Judit Giró Benet Interview: The Blue Box founder & inventor Judit Giró Benet")
Interview: The Blue Box inventor Judit Giró Benet Interview: The Blue Box founder & inventor Judit Giró Benet
Preparation of Clinical Documents for Public Disclosure
EMA pre-authorisation procedural advice for users of the centralised procedure
EMA Labelling and Packaging Regulations – Orphan Drug Consulting
Europe - ”Blue – Box” requirements - RIS.WORLD
An Analysis of Anonymization Practices in Initial Data Releases Pursuant to EMA Policy 0070
Novidades 20 de Outubro de 2020 - APREFAR - Associação dos Profissionais de Registos e Regulamentação Farmacêutica
Mock-ups and specimens review
Europe - Joint Strategy sets direction for EMA and EU Medicines Regulatory Agencies to 2025 - RIS.WORLD
Amlodipine besylate 10 mg tablet - $0.4 per 2 mg
201310108_Prizzi_M_EMA review process of medicines labelling and packaging_rev 08.10.13
